Literature DB >> 925962

Studies on the uptake and binding of propranolol by rat tissues.

D W Schneck, J F Pritchard, A H Hayes.   

Abstract

The tissue distribution of propranolol after i.v. administration (1.5 and 7.5 mg/kg) was studied in rats. Lung, brain and kidney showed extensive propranolol tissue binding. Propranolol uptake by lung seemed to be a saturable process. In contrast to the above tissues, liver propranolol concentrations remained low over the time period of study. An increase in the propranolol T1/2 was noted at the high dose and seemed to result from reduced systemic clearance and an increase in the apparent volume of distribution. Microsomal and mitochondrial fractions from several tissues contained substantial amounts of propranolol after i.v. administration and in vitro incubation with homogenates. Cytosol proteins did not bind significant amounts of propranolol. Equilibrium dialysis studies with rat liver mitochondrial and microsomal fractions revealed both high affinity, low capacity propranolol binding sites and low affinity, high capacity sites. At low concentrations, propranolol interaction with rat liver microsomes produced a type I difference spectrum with high affinity binding of similar magnitude to that observed with equilibrium dialysis. Higher concentrations of propranolol produced a saturable shift in the difference spectra with reduced binding affinity for propranolol. Results from these studies indicate that particulate fractions from several tissues contribute to the extensive tissue binding of propranolol.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925962

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  23 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

Authors:  M A van Baak; J M Mooij; P M Schiffers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats.

Authors:  N Yata; T Toyoda; T Murakami; A Nishiura; Y Higashi
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

4.  Binding of basic drugs to rat lung mitochondria.

Authors:  R Hori; K Okumura; H Yoshida
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

5.  Subcellular distribution of basic drugs accumulated in the isolated perfused lung.

Authors:  H Yoshida; K Okumura; R Hori
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

6.  Role of phosphatidylserine in the cellular and subcellular lung distribution of quinidine in rats.

Authors:  A Nishiura; T Murakami; Y Higashi; N Yata
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

7.  In vivo and in vitro studies of bacterial endotoxin-membrane interactions and the effects of membrane-active agents.

Authors:  M E Garnett; D V Godin; J M Tuchek
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

Review 8.  Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levels.

Authors:  Kyoung Ah Min; Xinyuan Zhang; Jing-yu Yu; Gus R Rosania
Journal:  Biopharm Drug Dispos       Date:  2013-12-10       Impact factor: 1.627

9.  Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase.

Authors:  A S Pappu; G Hauser
Journal:  Neurochem Res       Date:  1983-12       Impact factor: 3.996

10.  Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.

Authors:  T Terasaki; Y Sugiyama; T Iga; Y Sawada; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1985-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.